M. Arendse

SPAR – a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial

F. Frizelle, S. Ackland, C. Karapetis, 2019, BMC Cancer.

Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C.

R. Kirsch, I. Stander, M. Voigt, 1996, Journal of hepatology.

Neuro-Behçet’s disease presenting with tumour-like lesions and responding to rituximab

Z. Hussain, M. Arendse, D. White, 2016, Journal of Clinical Neuroscience.

Endometriosis in appendix and adjacent caecum with intestinal gland differentiation.

P. Russell, C. Lim, J. Kim, 2013, Pathology.

Eosinophilic gastroenteritis presenting as obstructive jaundice

I. S. Whitakera, M. Arendse, A. Gulatib, 2004 .

Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase‐2 and sialyl Lewis x antigen

L. Plank, M. Jameson, R. Gregor, 2015, ANZ journal of surgery.

SPAR: A randomized placebo-controlled phase 2 trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: An AGITG clinical trial.

F. Frizelle, S. Ackland, C. Karapetis, 2022, Journal of Clinical Oncology.